Your browser doesn't support javascript.
loading
Body mass index and type 2 diabetes and breast cancer survival: a Mendelian randomization study.
Liu, Yi-Shian; Wu, Pei-Ei; Chou, Wen-Cheng; Vikram, Rajeev; Chen, Wei-Ting; Yang, Show-Ling; Bolla, Manjeet K; Wang, Qin; Dennis, Joe; Chan, Tsun L; Choi, Ji-Yeob; Hou, Ming-Feng; Ito, Hidemi; Kang, Daehee; Kim, Sung-Won; Kwong, Ava; Matsuo, Keitaro; Park, Sue K; Shu, Xiao-Ou; Zheng, Wei; Dunning, Alison M; Easton, Douglas F; Shen, Chen-Yang.
Afiliação
  • Liu YS; Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan.
  • Wu PE; Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan.
  • Chou WC; Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan.
  • Vikram R; Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan.
  • Chen WT; Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan.
  • Yang SL; Institute of Biomedical Sciences, Academia Sinica Taipei, Taiwan.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge Cambridge, United Kingdom.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge Cambridge, United Kingdom.
  • Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge Cambridge, United Kingdom.
  • Chan TL; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre Happy Valley, Hong Kong, China.
  • Choi JY; Department of Pathology, Hong Kong Sanatorium and Hospital Happy Valley, Hong Kong, China.
  • Hou MF; Department of Biomedical Sciences, Seoul National University Graduate School Seoul, Korea.
  • Ito H; Cancer Research Institute, Seoul National University Seoul, Korea.
  • Kang D; Institute of Health Policy and Management, Seoul National University Medical Research Center Seoul, Korea.
  • Kim SW; Department of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital Kaohsiung, Taiwan.
  • Kwong A; Division of Cancer Information and Control, Aichi Cancer Center Research Institute Nagoya, Japan.
  • Matsuo K; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine Nagoya, Japan.
  • Park SK; Cancer Research Institute, Seoul National University Seoul, Korea.
  • Shu XO; Department of Preventive Medicine, Seoul National University College of Medicine Seoul, Korea.
  • Zheng W; Department of Surgery, Daerim Saint Mary's Hospital Seoul, Korea.
  • Dunning AM; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre Happy Valley, Hong Kong, China.
  • Easton DF; Department of Surgery, The University of Hong Kong Pok Fu Lam, Hong Kong, China.
  • Shen CY; Department of Surgery, Hong Kong Sanatorium and Hospital Happy Valley, Hong Kong, China.
Am J Cancer Res ; 11(8): 3921-3934, 2021.
Article em En | MEDLINE | ID: mdl-34522458

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article